2023
DOI: 10.1002/mc.23535
|View full text |Cite
|
Sign up to set email alerts
|

MYO1B as a prognostic biomarker and a therapeutic target in Arecoline‐associated oral carcinoma

Abstract: Background Arecoline, the main component of betel nut, induces malignant transformation of oral cells through complicated unclear mechanisms. Thus, we aimed to screen the key genes involved in Arecoline‐induced oral cancer and further verify their expressions and roles. Methods This study included a data‐mining part, a bioinformatics verification part, and an experimental verification one. First, the key gene related to oral cancer induced by Arecoline was screened. Then, the expression and clinical significan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 60 publications
(103 reference statements)
0
0
0
Order By: Relevance